www.medicalnewstoday.com Open in urlscan Pro
2600:9000:21f3:5200:0:db4d:7d40:93a1  Public Scan

Submitted URL: https://r20.rs6.net/tn.jsp?f=001_ameIn52i8yJwMWGDNsXBAccVIjxoXGhnxNqbWnnP3RKYiYUSjvl15cLWX8Y69dfpYQWR0thzEoAC5_I-UUg...
Effective URL: https://www.medicalnewstoday.com/articles/stimulation-of-brains-reward-center-can-help-with-treatment-resistant-depression
Submission: On October 25 via api from US — Scanned from DE

Form analysis 2 forms found in the DOM

/search

<form id="healthline-search-form" action="/search" class="css-70qvj9"><button type="submit" aria-label="Open Medical News Today Search" aria-expanded="false" data-testid="nav-search-button" class="css-6fmqbr"><svg viewBox="0 0 41 41" width="40"
      height="40" class="css-6hp203">
      <use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-search"></use>
    </svg></button></form>

POST /newsletter-signup

<form action="/newsletter-signup" method="post" novalidate="" class="css-30l4a7">
  <div class="css-8i1gnu"><input placeholder="Enter your email" aria-label="Enter your email" type="email" class="css-egeqy3 mnt-id-class"></div><button class="mnt-id-class css-1moygdh" type="submit"><span class="css-14ktbsh"><span
        class="css-1huyk6v">SUBSCRIBE</span></span></button>
</form>

Text Content

PLEASE ACCEPT OUR PRIVACY TERMS

You can change your preferences at any time by clicking on “Privacy Settings” in
the footer at the bottom of the page.

We believe that trustworthy health information should be free to everyone and we
rely on advertising to make that possible. Providing authoritative experiences
that are reviewed by physicians and other health and wellness professionals is
expensive, but it’s an invaluable service. We collect and securely process your
personal data to deliver a relevant experience and support our business, so we
ask that you allow cookies in order to access all of our content and features.

We and our partners process your personal data in the following ways:

 * cookies or unique IDs, for storing and/or accessing information on your
   device
 * personalized ads and content
 * ad and content measurement
 * audience insights and product development
 * ensuring security, preventing fraud, and debug
 * technically deliver ads or content

Your personal data use applies only while using Healthline Media Websites and
Apps. Some of our partners do not ask for your consent to process your data and
rely on their legitimate business interest. You can modify your setting or
object by clicking on “Manage Settings.”

At this time, we cannot provide the full site experience if you disallow any
purposes, features, or partners. Instead, we will provide a version of our site
that shows 10 of our most popular articles without ads, cookies, or tracking
technologies.

ACCEPT AND CONTINUE TO SITEMANAGE SETTINGS
 * Health Conditions
   * Health Conditions
     * Alzheimer's & Dementia
     * Anxiety
     * Arthritis
     * Asthma & Allergies
     * Breast Cancer
     * Cancer
     * Cardiovascular Health
     * COVID-19
     * Dermatology & Skincare
     * Diabetes
     * Environment & Sustainability
     * Exercise & Fitness
     * Eye Health
     * Headache & Migraine
     * Health Equity
     * HIV & AIDS
     * Human Biology
     * Inflammatory Bowel Disease
     * Leukemia
     * LGBTQIA+
     * Men's Health
     * Mental Health
     * Multiple Sclerosis (MS)
     * Nutrition
     * Parkinson's Disease
     * Psoriasis
     * Sexual Health
     * Women's Health
 * Discover
   * News
     * Latest News
   * Original Series
     * Medical Myths
     * Honest Nutrition
     * Through My Eyes
     * New Normal Health
   * Podcasts
     * How to understand chronic pain
     * What is behind vaccine hesitancy?
     * The amazing story of hepatitis C, from discovery to cure
     * New directions in dementia research
     * Can psychedelics rewire a depressed, anxious brain?
     * Why climate change matters for human health
 * Tools
   * General Health
     * Drugs A-Z
     * Health Hubs
   * Health Tools
     * BMI Calculators and Charts
     * Blood Pressure Chart: Ranges and Guide
     * Breast Cancer: Self-Examination Guide
     * Sleep Calculator
   * Health Products
     * Affordable Therapy Options
     * Blood Pressure Monitors
     * Diabetic Supplies
     * Fitness Trackers
     * Home Gyms
     * Green Cleaning Products
     * How to Shop for CBD
   * Quizzes
     * RA Myths vs Facts
     * Type 2 Diabetes: Managing Blood Sugar
     * Ankylosing Spondylitis Pain: Fact or Fiction
 * Connect
   * About Medical News Today
     * Who We Are
     * Our Editorial Process
     * Content Integrity
     * Conscious Language
   * Newsletters
     * Sign Up
   * Follow Us

Participate in Depression Awareness Month with our community

MEET BEZZY

Medical News Today
 * Health Conditions
 * Discover
 * Tools
 * Connect

Subscribe






STIMULATION OF BRAIN'S 'REWARD' CENTER CAN HELP WITH TREATMENT-RESISTANT
DEPRESSION

By Corrie Pelc on August 26, 2022 — Fact checked by Ferdinand Lali, Ph.D.
Share on PinterestWhich brain area should deep brain stimulation target in order
to improve treatment-resistant depression? Researchers may have found an answer.
Image credit: artpartner-images/Getty Images.
 * About 30% of people with major depressive disorder (MDD) develop
   treatment-resistant depression.
 * Researchers from UTHealth Houston say deep brain stimulation applied to
   certain areas of the brain may help treat it.
 * The research team found that depression in 8 out of 10 treatment-resistant
   patients decreased by at least 50% after deep brain stimulation.

About 30% of peopleTrusted Source receiving care for major depressive disorder
have treatment-resistant depression. Treatment-resistant depression occurs when
a person does not respond to at least two different antidepressant medications.

Treatment options for this form of depression include additional medications,
psychotherapy, and brain stimulationTrusted Source.

Now, a team of researchers from UTHealth Houston has found that delivering deep
brain stimulation to the areas of the brain related to reward and motivation may
help alleviate treatment-resistant depression.

This study recently appeared in the journal Molecular PsychiatryTrusted Source.


WHAT IS TREATMENT-RESISTANT DEPRESSION?

The World Health Organization (WHO) ranks depression as the most common illness
in the worldTrusted Source, affecting about 3.8% of the global population.

Major depressive disorder or clinical depression is a mood disorder that impacts
a person’s daily life. Symptoms of depression include:

 * fatigue
 * sleeping issues
 * concentration problems
 * anxiety and/ or nervousness
 * changes in appetite
 * anger and/ or irritability
 * thoughts of self-harm and/ or suicide.

The treatment for depression normally includes medication, psychotherapy, or a
combination of both. Medications for depression can include
antidepressantsTrusted Source, antipsychoticsTrusted Source, and mood
stabilizersTrusted Source.

If a person receiving treatment for depression does not respond to at least
twoTrusted Source different antidepressant medications, they may have
treatment-resistant depression.

Current treatments for this include:

 * augmentation therapyTrusted Source, where a doctor prescribes an
   antidepressant medication and a second medication that is usually not an
   antidepressant
 * psychotherapy
 * brain stimulation
 * novel treatmentsTrusted Source, such as psilocybin or anti-inflammatory
   drugsTrusted Source.

ADVERTISEMENT
Online therapy can help with depression

Improve your quality of life with the support of BetterHelp's licensed
therapists. Get therapy when you need it over phone, video, or chat.

LEARN MORE

WHAT IS DEEP BRAIN STIMULATION? 

Deep brain stimulationTrusted Source is a neurosurgical treatment where
electrodes are implanted into the brain. The electrodes send out electrical
signals to the brain, helping to change and correct the way in which it
operates.

Over 160,000Trusted Source people globally have received deep brain stimulation
treatment for both neurological and non-neurological issues.

Deep brain stimulation is commonly used to treat movement disorders such as
Parkinson’s disease and dystonia. Researchers have also studied it as a
potential treatment for treatment-resistant depression.

A systematic review of clinical outcomes published in 2014 found that 40-70% of
people with treatment-resistant depression treated with deep brain stimulation
showed an improvement of over 50% in their symptoms.

“Unfortunately, despite all resources we have to treat depression and even
treatment-resistant depression, not all patients respond to them,” explained Dr.
João de Quevedo, professor in the Louis A. Faillace, MD, Department of
Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth
Houston, and a co-author of the study.

“Invasive treatment strategies including deep brain stimulation come to address
the unmet needs of this treatment-resistant depression subpopulation,” he added.

TARGETING THE BRAIN’S REWARD AND MOTIVATION CENTER

According to Dr. de Quevedo, the purpose of this research study was to show the
efficacy of their surgical approach in improving depressive symptoms of people
living with treatment-resistant depression.

“Despite [having] a rationale for choosing this specific target to land the
electrodes, we need further evidence on which brain structures are activated
downstream,” he told Medical News Today. “It generates a kind of roadmap of
additional targets for treatment.”

During the study, Dr. de Quevedo and his team examined applying deep brain
stimulation to the superolateral branch of the medial forebrain bundleTrusted
Source in the brain. This area of the brain is related to reward and motivation.

Researchers applied deep brain stimulation to this particular area of the brain
in 10 patients. Using PET scansTrusted Source conducted at 6 months and at 1
year following deep brain stimulation treatment, researchers found metabolic
brain changes in 8 of the 10 patients, indicating a decrease in a patient’s
markers of depression of at least 50%.

“We are paving the road that will lead us to large-scale clinical trials and
therefore FDA approval,” Dr. de Quevedo stated. “Our proof-of-concept study is a
starting point, not the end.”


‘EXCITING’ POTENTIAL NEW THERAPY

Dr. Jean-Philippe Langevin, neurosurgeon and director of Restorative
Neurosurgery and Deep Brain Stimulation Program for Pacific Neuroscience
Institute at Providence Saint John’s Health Center in Santa Monica, CA, said
this new research is “exciting” as a potential new therapy for an area where
there are currently not many options.

“The majority of patients with depression are going to get better with
medication or psychotherapy, but there’s a small group that does not improve,”
he explained to MNT.

“And so for those patients,” he added, “there’s not a whole lot of options out
there. It was nice to see that in another line of evidence that perhaps
neurosurgery could offer some help in the future.”

Dr. Langevin said clinicians are now discovering that patients with depression —
and in particular, treatment-resistant depression — have anomalies or abnormal
ways in which the brain is functioning or processing emotion.

“It could be that in those patients perhaps it’s a condition where the brain was
wired that way, or sometimes it could be that events or medical conditions in
life happen and change the way your brain is wired slightly and make it very
difficult to get out of that feeling or those symptoms of depression,” he
explained.

> “In deep brain stimulation, we can alter the way the brain works in a more
> focal way. You can target those areas of the brain that are either too active
> or not active enough, and then switch their activity slightly or modulate it
> in a way that’s more conducive to proper emotional processing.”
> 
> – Dr. Jean-Philippe Langevin

When asked what he would like to see in future research, Dr. Langevin mentioned
that while there has been other research examining the use of deep brain
stimulation for treatment-resistant depression in different ways, he would like
to see a more individualized approach.

“One patient may benefit from [deep brain stimulation] in one specific area
versus another one and another area,” he noted. “That could explain why some
patients [respond] in those trials, whereas other ones may not be responding as
well.”

“In general, I think what we need is continuing to pursue the work with larger
studies to prove whether or not we’re on the right track,” Dr. Langevin added.


 * Mental Health
 * Neurology / Neuroscience
 * Psychology / Psychiatry

By Corrie Pelc on August 26, 2022 — Fact checked by Ferdinand Lali, Ph.D.




LATEST NEWS

 * Immune reaction to a gut bug may trigger rheumatoid arthritis
 * Why are scientists growing human brain cells in the lab?
 * Not treating depression might heighten future dementia risk
 * Why do we procrastinate? Experts explain the science
 * Parkinson's disease: Zinc may enhance a protein's protective role


WAS THIS ARTICLE HELPFUL?

YesNo



RELATED COVERAGE


 * How long-term depression alters the brain
   
   Research has shown that depression is tied to biological changes in the
   brain. But do such changes worsen over time, and are current treatments…
   
   READ MORE
   
 * Severe depression linked with inflammation in the brain
   
   A new study claims to be the first to find 'definitive evidence' of an
   association between brain inflammation and major depression.
   
   READ MORE
   
 * Exercise as a depression treatment: What to know
   Medically reviewed by Timothy J. Legg, PhD, PsyD
   
   There is a growing body of research suggesting that exercise could help treat
   depression. In this article, learn about the possible effects and what…
   
   READ MORE
   
 * Could mindfulness prevent major depression?
   
   A weekly session of mindfulness meditation may help to prevent the
   development of major depression in those with subclinical depression, a new
   study…
   
   READ MORE
   
 * What to know about TMS treatment for depression
   
   TMS is a noninvasive therapy that doctors may recommend for people with
   treatment-resistant depression. Learn more.
   
   READ MORE
   







GET OUR NEWSLETTER

Keep up with the ever-changing world of medical science with new and emerging
developments in health.


SUBSCRIBE

Your privacy is important to us. Any information you provide to us via this
website may be placed by us on servers located in countries outside of the EU.
If you do not agree to such placement, do not provide the information.

 * About Us
 * Contact Us
 * Terms of Use
 * Privacy Policy
 * Privacy Settings
 * Advertising Policy

 * Health Topics
 * Health Hubs
 * Medical Affairs
 * Content Integrity
 * Newsletters
 * © 2004-2022 Healthline Media UK Ltd, Brighton, UK, a Red Ventures Company.
   All rights reserved. MNT is the registered trade mark of Healthline Media.
   Any medical information published on this website is not intended as a
   substitute for informed medical advice and you should not take any action
   before consulting with a healthcare professional. See additional information.

© 2004-2022 Healthline Media UK Ltd, Brighton, UK, a Red Ventures Company. All
rights reserved. MNT is the registered trade mark of Healthline Media. Any
medical information published on this website is not intended as a substitute
for informed medical advice and you should not take any action before consulting
with a healthcare professional. See additional information.
AboutCareersAdvertise with us

OUR BRANDS

HealthlineMedical News TodayGreatistPsych Central